ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,877Medicare Part D Prescriptions Filled, Including Refills

Rank: 111 out of 2094

$887K Total Retail Price of All Prescriptions

Rank: 141 out of 2094

923 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 923 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

3% of this provider’s 923 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 10,904 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 498 475 1 1
AMLODIPINE BESYLATE 381 341 2 2
LEVOTHYROXINE SODIUM 358 313 3 3
ATORVASTATIN CALCIUM 356 334 4 5
FUROSEMIDE 314 307 5 6
LISINOPRIL 294 287 6 7
PRAVASTATIN SODIUM 276 275 7 18
OMEPRAZOLE 259 249 8 4
WARFARIN SODIUM 215 200 9 11
METOPROLOL SUCCINATE 199 175 10 9
METOPROLOL TARTRATE 193 191 11 10
LOSARTAN POTASSIUM 193 188 11 17
METFORMIN HCL 176 129 13 8
HYDROCHLOROTHIAZIDE 148 148 14 12
PANTOPRAZOLE SODIUM 144 135 15 37
DIOVAN 139 120 16 13
POTASSIUM CHLORIDE 138 116 17 24
ATENOLOL 130 117 18 21
AZITHROMYCIN 128 117 19 27
NEXIUM 125 118 20 16
ZOLPIDEM TARTRATE 124 111 21 14
DONEPEZIL HCL 122 122 22 20
NAMENDA 115 115 23 32
ESCITALOPRAM OXALATE 111 103 24 46
TAMSULOSIN HCL 110 110 25 29
LIPITOR 106 88 26 39
ALENDRONATE SODIUM 105 94 27 30
GLYBURIDE 102 86 R 28 95
PAROXETINE HCL 102 101 28 77
ENALAPRIL MALEATE 102 102 28 25
SERTRALINE HCL 100 100 31 26
HYDROCODONE-ACETAMINOPHEN 98 72 S3 32 42
CRESTOR 97 86 33 15
GLIMEPIRIDE 97 93 33 31
MELOXICAM 94 93 35 49
LOSARTAN-HYDROCHLOROTHIAZIDE 93 92 36 52
DIGOXIN 93 82 36 51
FLUTICASONE PROPIONATE 90 72 38 41
MIRTAZAPINE 89 89 39 43
SYNTHROID 89 71 39 44
RAMIPRIL 88 86 41 48
FINASTERIDE 82 82 42 97
GABAPENTIN 80 79 43 23
ALLOPURINOL 80 80 43 50
CEFUROXIME 78 68 45 137
CLOPIDOGREL 78 78 45 22
CARVEDILOL 77 77 47 19
CITALOPRAM HBR 75 62 48 47
PLAVIX 70 70 49 38
TORSEMIDE 64 54 50 118
TRAMADOL HCL 62 42 51 33
SANTYL 61 61 52 114
QUINAPRIL HCL 60 60 53 123
ADVAIR DISKUS 59 47 54 36
MUPIROCIN 57 56 55 117
TRIAMTERENE-HCTZ 57 57 55 87
OXYCODONE-ACETAMINOPHEN 56 51 S2 57 40
LIDODERM 55 43 58 59
CIPROFLOXACIN HCL 50 47 59 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.